| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. | Chief Legal Officer | Common Stock | 25K | $1.13M | $45.01 | Aug 1, 2024 | Direct |
| Avidity Biosciences, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 160K | Aug 1, 2024 | Direct | ||
| Olema Pharmaceuticals, Inc. | EVP, Ch. Legal Officer & Sec. | Stock Option (Right to Buy) | 150K | Feb 1, 2023 | Direct | ||
| Mirati Therapeutics, Inc. | Chief Legal Officer | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
| Mirati Therapeutics, Inc. | Chief Legal Officer | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | Aug 1, 2024 | 2 | $0 | 4 | Aug 5, 2024 | Chief Legal Officer |
| RNA | Avidity Biosciences, Inc. | Aug 1, 2024 | 0 | $0 | 3 | Aug 5, 2024 | Chief Legal Officer |
| MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 3 | $0 | 4 | Jan 23, 2024 | Chief Legal Officer |
| MRTX | Mirati Therapeutics, Inc. | Aug 9, 2023 | 1 | $825K | 4 | Aug 10, 2023 | Chief Legal Officer |
| MRTX | Mirati Therapeutics, Inc. | Jun 23, 2023 | 0 | $0 | 3 | Jun 23, 2023 | Chief Legal Officer |
| OLMA | Olema Pharmaceuticals, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 2, 2023 | EVP, Ch. Legal Officer & Sec. |
| OLMA | Olema Pharmaceuticals, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | EVP, CH. LEGAL OFFICER & SEC. |